Diseases & Disorders · NJ
Congenital Hyperinsulinism International
Congenital Hyperinsulinism International reported paying Julie Raskin, Ceo, $114,071 in total compensation (FY 2024).
That places Julie Raskin at approximately the 42nd percentile among 24 similarly sized diseases & disorders nonprofits (median $121,543).
$1,275,774Total revenue (FY 2024)
$114,071Total executive compensation
42ndPercentile vs. peers
Setting executive pay for this board?
Generate a board-ready comparability report for Congenital Hyperinsulinism International — named comparables, percentiles, methodology, and the 26 CFR 53.4958-6 minutes language a board can use toward the rebuttable presumption.
Build the comparability report →Comparable diseases & disorders nonprofits
Compensation is normalized to NJ cost of living (BEA Regional Price Parities); each organization's reported figure is on its linked 990.
| Organization | State | Revenue | Total comp |
|---|---|---|---|
| Bina Stroke And Brain Injury | NY | $1,245,269 | $172,968 |
| Mission Clinical Services | AR | $1,230,992 | $17,043 |
| A Breath Of Hope Lung Foundation | MN | $1,229,594 | $171,048 |
| Lung Cancer Initiative | NC | $1,186,472 | $119,292 |
| Emilio Nares Foundation | CA | $1,370,788 | $123,794 |
| Diabetes Research Connection | CA | $1,176,901 | $153,197 |
| Hnc Living Foundation | KS | $1,162,460 | $185,655 |
| The Cancer Foundation Inc | GA | $1,391,502 | $124,590 |